Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Alternative Exercises

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed2
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT04273867Completed

Assessing Health Related Quality of Life in Hypersensitivity Pneumonitis

NCT04561479Not ApplicableUnknown

Pulmonary Rehabilitation in Patients With Chronic Fibrotic Hypersensitivity Pneumonitis

NCT01237145CompletedPrimary

Bronchoalveolar Immune Response Determination

Showing all 3 trials

Research Network

Common Treatments

  • Alternative Exercises1
  • Chronic Hypersensitivity Pneumonitis Health Related Quality Of Life Survey Instrument1
  • Pulmonary Rehabilitation1

Active Sponsors

  • Bossink, A.W.J.1
  • Pulmonary Fibrosis Foundation1
  • Gazi University1
  • Weill Medical College of Cornell University1

Top Investigators

Related Conditions

  • Hypersensitivity Pneumonitis2
  • Chronic Hypersensitivity Pneumonitis1
  • Interstitial Lung Disease1
  • Healthrelated Quality Of Life1

Activity Timeline